Logo.png
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
06 mars 2020 08h05 HE | Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
Logo.png
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
07 janv. 2020 11h02 HE | Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Logo.png
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
14 nov. 2019 07h00 HE | Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
Logo.png
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF
23 oct. 2019 07h00 HE | Guardion Health Sciences, Inc.
San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for...
Logo.png
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test
03 sept. 2019 07h00 HE | Guardion Health Sciences, Inc.
New Generation of Vision Testing Technology to be Introduced at Vision Expo West San Diego, CA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Logo.png
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering
15 août 2019 16h05 HE | Guardion Health Sciences, Inc.
San Diego, CA , Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...
Logo.png
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering
15 août 2019 08h35 HE | Guardion Health Sciences, Inc.
San Diego, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), previously announced the pricing of an underwritten public offering of...
Logo.png
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
13 août 2019 09h00 HE | Guardion Health Sciences, Inc.
San Diego, CA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 13,000,000...
Logo.png
Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations
12 août 2019 08h40 HE | Guardion Health Sciences, Inc.
Highlights Include:  18.2% Revenue Growth for the Three Months Ended June 30, 2019 and 21.7% Revenue Growth for the Six Months Ended June 30, 2019 San Diego, CA , Aug. 12, 2019 (GLOBE...
Logo.png
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical Trial
06 août 2019 07h00 HE | Guardion Health Sciences, Inc.
The CSV-1000 Diagnostic Instrument is Considered the Standard of Care for the Measurement of Contrast Sensitivity San Diego, CA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc....